PHMB-based Antiseptic Use in Full-thickness Surgical Wounds

Sponsor
Region Skane (Other)
Overall Status
Completed
CT.gov ID
NCT02253069
Collaborator
Vinnova (Other)
40
1
2
12
3.3

Study Details

Study Description

Brief Summary

To study the effect of applying a PHMB-based antiseptic solution to tie-over dressings in full-thickness surgical wounds in dermatologic surgery in order to minimise the development of surgical site infections. The bacterial dynamics in wounds pre-,intra-, and postoperatively will be examined in order to understand the pathogenesis of surgical site infections better.

Condition or Disease Intervention/Treatment Phase
  • Device: Applying Prontosan antiseptic solution to tie-over dressings
  • Device: Applying Placebo to tie-over dressings
N/A

Detailed Description

40 patients with suspected skin cancer in the face planned for full-thickness surgery will be randomised into two groups: One will receive a traditional tie-over dressing saturated with NaCl and the other group will receive a tie-over dressing saturated with a PHMB-based antiseptic. A quantitative and qualitative bacterial analysis of wounds by using a modified Levine's swabbing technique will be carried out pre-,intra-,and postoperatively. The effect of nasal colonisation with S.aureus on the development of surgical site infections will be investigated. All wounds will be followed a week after surgery to assess development of infections.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
A Study of Polyhexanide-based Antiseptic in Full-thickness Surgical Wounds in Dermatologic Surgery
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Sep 1, 2015
Actual Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: PHMB-based antiseptic

Applying Prontosan antiseptic solution to tie-over dressings

Device: Applying Prontosan antiseptic solution to tie-over dressings
Applying a PHMB-based antiseptic to tie-over dressings

Placebo Comparator: Control

Applying water to tie-over dressings

Device: Applying Placebo to tie-over dressings
Placebo control

Outcome Measures

Primary Outcome Measures

  1. Measuring colony forming units in swabs collected from wounds pre-,intra- and postoperatively (7 days after surgery1). Change in bacterial load will be attributed to the effect of applying an antiseptic solution to wound dressings. [7 days]

    Wounds will be swabbed at end of surgery and then 7 days after surgery. Number and type of bacteria present will be analysed. Our hypothesis is that applying the antiseptic solution to the tie-over dressings will show a suppressed growth of bacteria when measured 7 days after surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients planned for full-thickness skin grafting in the face
Exclusion Criteria:
  • Patients with no diabetes

  • Patients with no current/previous/recent antibiotic therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of dermatology, Skåne university hospital Lund Sweden 22185

Sponsors and Collaborators

  • Region Skane
  • Vinnova

Investigators

  • Principal Investigator: Karim Saleh, MD, Department of Dermatology, Skåne University Hospital, Lund

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Karim Saleh, Dr., Region Skane
ClinicalTrials.gov Identifier:
NCT02253069
Other Study ID Numbers:
  • Regionskane
First Posted:
Oct 1, 2014
Last Update Posted:
Dec 9, 2015
Last Verified:
Dec 1, 2015

Study Results

No Results Posted as of Dec 9, 2015